CEPHALON INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2010-12-09: Study NCT01240694; Company role Lead sponsor; Phase Phase 3; Status Terminated.
- 2010-07: Study NCT01177683; Company role Collaborator; Phase Phase 1, Phase 2; Status Terminated.
- 2010-06-24: Study NCT01135459; Company role Lead sponsor; Phase Phase 2; Status Completed.
- 2010-04: Study NCT01014546; Company role Collaborator; Phase Phase 1; Status Terminated.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2010-12-09 | NCT01240694 A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus | Lead sponsor | Phase 3 | Terminated Results posted | Systemic Lupus Erythematosus | 136 | 2012-06-14 |
| 2010-07 | NCT01177683 Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma | Collaborator Lead: Sherif Farag, MB, BS | Phase 1, Phase 2 | Terminated Results posted | Multiple Myeloma | 32 | 2017-12 |
| 2010-06-24 | NCT01135459 A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) | Lead sponsor | Phase 2 | Completed Results posted | Systemic Lupus Erythematosus | 183 | 2012-06-30 |
| 2010-04 | NCT01014546 Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis | Collaborator Lead: Roswell Park Cancer Institute | Phase 1 | Terminated | Essential Thrombocythemia; Polycythemia Vera; Primary Myelofibrosis | 5 | 2015-02 |
| 2009-08-31 | NCT00983437 Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury | Lead sponsor | Phase 3 | Terminated Results posted | Traumatic Brain Injury | 49 | 2011-01-31 |
| 2009-06-30 | NCT01792583 The Nuvigil and Provigil Pregnancy Registry | Lead sponsor | Observational | Terminated | Narcolepsy; Obstructive Sleep Apnea; Shift Work Sleep Disorder | 191 | 2023-11-30 |
| 2009-06 | NCT01041495 Cyclobenzaprine Extended Release (ER) for Fibromyalgia | Collaborator Lead: State University of New York - Upstate Medical University | Phase 4 | Terminated Results posted | Fibromyalgia; Pain; Sleep; Fatigue | 37 | 2013-03 |
| 2009-04-30 | NCT00893789 Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury | Lead sponsor | Phase 3 | Terminated Results posted | Traumatic Brain Injury | 117 | 2011-01-31 |
| 2008-10-13 | NCT00712881 Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer | Lead sponsor | Phase 2 | Completed Results posted | Breast Cancer | 126 | 2015-09-17 |